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Developing ontologies to account for the complexity of biological systems requires the time intensive col-
laboration of many participants with expertise in various ﬁelds. While each participant may contribute to
construct a list of terms for ontology development, no objective methods have been developed to evalu-
ate how relevant each of these terms is to the intended domain. We have developed a computational
method based on a hypergeometric enrichment test to evaluate the relevance of such terms to the
intended domain. The proposed method uses the PubMed literature database to evaluate whether each
potential term for ontology development is overrepresented in the abstracts that discuss the particular
domain. This evaluation provides an objective approach to assess terms and prioritize them for ontology
development.
 2009 Elsevier Inc. All rights reserved.1. Introduction
High-quality ontologies such as the Gene Ontology (GO) [1]
have been instrumental in analyzing data generated from micro-
array experiments [2–13]. However, developing such high-quality
ontologies still poses signiﬁcant challenges, as a wide range of lit-
erature and domain experts need to be involved. To aid ontology
development, numerous methods have been developed to extract
terms from literature automatically. Daille proposed combined
techniques to extract terms automatically from corpora by com-
bining linguistic ﬁlters and statistical methods [14]. Frantzi et al.
developed a C-value/NC-value method to extract multi-word terms
automatically [15]. By taking advantage of semantic relations en-
coded between terms, Grabar and Zweigenbaum developed a
two-step approach to collect semantically related terms and to
align morphologically linked work forms for term extraction [16].
A ‘‘weirdness metric” was proposed by Ahmad and Rogers to
evaluate terms overrepresented in the domain-speciﬁc corpus for
ontology development [17]. Savova et al. developed a data-driven
approach to extract the ‘‘most speciﬁc term” for ontology develop-
ment using an algorithm combining statistical and linguistic
approaches [18]. Another tool developed to extract terms for ontol-
ogy development was Text2Onto, which was built upon the
Probabilistic Ontology Model [19]. In addition, Smith et al. pro-
posed a machine learning approach to retrieve deﬁnitional content
for ontology development [20]. Concept maps have also been used
by Castro et al. in the ontology development process [21]. Alexo-ll rights reserved.
work.poulou et al. developed two additional methods, one based on
the relative frequency of a term in the corpus and the other using
the document frequency derived from all phrases contained in
PubMed abstract database, to extract terms for ontology develop-
ment [22]. While these methods focus on extracting terms from
the published literature, two other studies also proposed to extract
terms from web resources for concept and ontology development
[23,24]. Despite these efforts, it is still widely recognized that man-
ual curation is the most reliable method for ontology development
[25], and these automatic term extraction methods are rarely used
as a mainstream approach in the current biomedical ontology
development process.
In the manual curation process, curators read as much scientiﬁc
literature as possible for a particular biological domain in order to
identify corresponding ontology terms and to classify their rela-
tionships to the domain and to other terms within it (such as ‘‘is_a”
and ‘‘has_a” relationships). One signiﬁcant challenge during this
process is to determine which terms should be used as the basic
building blocks from which to develop an ontology for a particular
domain. This challenge is compounded by the fact that many cura-
tors with diverse backgrounds may be involved in developing the
ontology for a given domain; diversity in their backgrounds can
result in the selection of a wide variety of terms to be compiled
within the ontology. This term selection process relies on the
expertise of individual curators, without either a preliminary or
conﬁrmatory test using some objective method and measure. A
quantitative approach to evaluate whether terms are appropriate
to develop an ontology for a particular domain would provide this
objective method and measure, improve the utility of the resulting
ontology, and reduce the amount of work imposed on curators.
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Fig. 1. Workﬂow of enrichment test to evaluate terms for ontology development.
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underlying metrics have the potential to be used to evaluate terms
assembled by experts duringmanual curation for ontology develop-
ment, several limitations exist for such an application. First, most of
these algorithms are developed to extract terms from a corpus of
selected literatures already identiﬁed by experts (in many cases
involvingmanual selection) as relevant to a speciﬁc domain. Lacking
such a pre-deﬁned corpus, as is the case formany ontology develop-
ment projects, the effectiveness of these methods is not clear.
Second, the volume of existing literature databases like PubMed is
signiﬁcantly larger than a corpus related to a speciﬁc domain; this
corpus size difference raises questions about the performance of
these algorithms if applied to evaluate terms using PubMed
abstracts in the absence of a domain-speciﬁc corpus. Furthermore,
thesemethodshavenotbeenwidely testedagainstmanually assem-
bled ontology terms. New approaches capable of dealing with large
databases and conﬁrmed through comparison to manually curated
ontologies need to be developed.
One objective criterion to evaluate a term’s suitability for incor-
poration in an ontology for a particular concept domain is to quan-
tify the term’s relevance to the domain within published
biomedical literature. If a term occurs at high frequency in PubMed
abstracts relevant to the concept domain, then it should be more
suitable for ontology development than other terms occurring at
low frequencies. Because ontology development aims to describe
particular biological domains, we hypothesized that the terms
used within an already existing ontology for a particular domain
would be overrepresented in the PubMed abstracts relevant to that
domain (Domain PubMed Abstract, DPA). We further hypothesized
that the degree of overrepresentation could be detected by
employing a hypergeometric enrichment test.
Testingbasedonhypergeometricdistributionhasbeenapplied in
the analysis of GO overrepresentation on biologically-interesting
gene sets (review see [26]). Hypergeometric testing can measure
the association between a term and the domain by calculating the
probability of observing the termwithin theDPA as long as both cat-
egories are sampled without replacement from a ﬁnite population.
Such a probability can be used as a direct measure of how relevant
a term is to the domain: the higher probability we observe a term
in the DPA, the more overrepresented this term is in the DPA, and
the more relevant this term is. The degree of overrepresentation of
terms relevant to a domain in the DPA can indicate the usefulness
of the terms for developing this domain’s ontology. Experts from
diverse ﬁelds could use the information gleaned through such a
hypergeometric evaluation to narrow candidate terms for a given
ontology. The test could signiﬁcantly reduce the manual effort
involved in ontology development.
In this study, we ﬁrst used GO [1] as a control to evaluate
whether the proposed text-mining approach could detect the
overrepresentation of ontology terms in the corresponding DPA.
We demonstrated that the hypergeometric test could capture the
relevant terms in the DPA and reﬂect their relative importance
by their overrepresentation. We then demonstrated that this
approach could be used to evaluate putative ontology terms gener-
ated by different experts for the development of a Clinical Trial
Ontology/Ontology for Clinical Investigation [27]. Our results
indicated that such a computational algorithm can provide an
objective measure for the selection of putative ontology terms to
facilitate ontology development.
2. Methods
2.1. PubMed database preparation
Fig. 1 illustrates a condensed version of our process. The entire
PubMed database (2007) in XML format was downloaded fromNCBI. The database was processed to extract all abstracts. Neces-
sary formatting, such as capitalizing all the abstracts and removing
special characters, was performed (box ‘preprocessing’). All the
software was implemented in C++. PubMed stopwords were also
downloaded from NCBI.
2.2. Collection of GO and other terms
Terms for evaluation by hypergeometric enrichment test: In order
to test whether terms relevant to a domain were overrepresented
in the corresponding DPA, we identiﬁed test sets where each set
had a domain term and a list of terms known to be relevant to that
domain. To generate these test sets, we took advantage of the hier-
archical structure of GO. In an ontology such as GO, terms with
speciﬁc meaning are children of terms that are more general, thus
comprising an ‘‘is_a” relationship. We viewed a parent term as a
domain and the child term as a term relevant to that domain. This
approach can be extrapolated to multi-level hierarchies such that
an ontology term at a high level of the hierarchy can be viewed
as a domain term, and all of its child terms can be viewed as terms
that are relevant to this domain.
GO was downloaded from the GO Consortium website (http://
www.geneontology.org, June, 2007). Two terms were selected
from GO as domain terms for our study. The criteria for selection
were: (1) each term had more than 50 child terms under an ‘‘is_a”
relationship to yield a signiﬁcant number of child terms relevant to
the domain; (2) the selected domain term was not a child term of
another domain term. Two domain terms, Monosaccharide Meta-
bolic Process (GO:0005996) and Protein Kinase Activity
(GO:0004672), were selected for this purpose. Monosaccharide
Metabolic Process is categorized as a biological process within
GO, and Protein Kinase Activity falls within the molecular function
category. Descendents of these two terms were also collected.
Since we focus on the terms that describe biological systems, com-
mon words such as ‘‘activity” or ‘‘process” were removed from
these descendent terms (henceforth, such terms are shown in
brackets). This practice was limited to the GO terms used for vali-
dation purposes and was not applied to the putative ontology
terms evaluated in subsequent analyses. The number of unique
terms after removing these common words was 56 and 97 for
Monosaccharide [Metabolic Process] and Protein Kinase [Activity],
respectively. The degree of overrepresentation of these descendent
terms in the DPA was tested as described below.
We also selected additional GO terms as controls. These terms
were randomly chosen from a pool of GO terms that had no
descendant-ancestor relationships with Monosaccharide [Meta-
bolic Process] or Protein Kinase [Activity]. The control terms iden-
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Fig. 2. Using PubMed abstract database and hypergeometric test to evaluate terms
for ontology development. (A) X is the number of abstracts that contains both a
term for ontology development (putative ontology term to be evaluated) and the
domain term; M and N are the abstracts with and without the term for the domain,
respectively; K is the number of abstracts with the term. M + N is the total number
of PubMed Abstracts examined. For example, to evaluate whether hexokinase
activity is an appropriate term to develop an ontology for monosaccharide
metabolism, X is the number of PubMed abstracts that contain both hexokinase
activity and monosaccharide metabolism. (B) The equation shows the probability of
observing X by employing the hypergeometric formulation, where aCb ¼ a!b!ðabÞ! is the
binomial coefﬁcient.
826 L.C. Tsoi et al. / Journal of Biomedical Informatics 42 (2009) 824–830tiﬁed as overrepresented in abstracts that also included Monosac-
charide [Metabolic Process] or Protein Kinase [Activity] were
counted as false positives in constructing Precision–Recall curves.
Terms for evaluating putative ontology terms for Clinical Trial
Ontology: Putative ontology terms were downloaded from the wiki
for the Ontology for Clinical Investigations [27]. These 316 terms
were assembled by experts with various experience and
backgrounds in areas related to clinical trials. The domain of clin-
ical trials focuses on clinical trial design, implementation and
outcome analysis, while the domain of GO mainly characterizes
gene functions. Therefore, we assumed that the overlap between
these two domains would be small and not signiﬁcant. This
assumption is supported by the fact that the PubMed abstracts
containing the word ‘‘protein kinase” comprise only 0.1% of those
containing the keyword ‘‘clinical trial”, and the PubMed abstracts
that contain the word ‘‘clinical trial” only comprise 0.4% of those
with the keyword ‘‘protein kinase”. The low frequency of GO terms
appearing in the PubMed abstracts that contain the keyword
‘‘clinical trial” also supports our assumption (data not shown).
Therefore, randomly selected GO terms were used as negative
controls: if any of these GO terms were overrepresented in the
PubMed abstracts that discussed clinical trials, they were counted
as false positives. The selected terms were mapped to the PubMed
abstracts, and their occurrences in the abstracts relevant to the
clinical trial domain were counted. For the clinical trial domain,
we identiﬁed any PubMed abstracts that contained the term ‘‘Clin-
ical Trial” or ‘‘Clinical-Trial” as relevant. The ﬁnal test was run for
all 316 putative ontology terms and identiﬁed terms that were
overrepresented in the DPA for the clinical trial domain.
2.3. Mapping terms to PubMed abstracts
We implemented the efﬁcient Boyer–Moore string search algo-
rithm [28] in C++ to map terms to PubMed abstracts. The algorithm
identiﬁes single or multi-word terms between white space in the
abstracts that match query terms. Mapping of terms to PubMed
abstracts was performed on a 76 node computer cluster. Each clus-
ter node had two dual-core Intel Xeon 3GB processors. The PubMed
database was split into 100 ﬁles, and mapping was performed on
100 cluster nodes for the selected GO terms, the putative ontology
terms for Clinical Trial Ontology development, and the domain
terms. The numbers of abstracts that contained individual terms
were then summed. The results were assembled and analyzed by
the hypergeometric test.
2.4. Performing the hypergeometric test and the Weirdness Metric test
In this study, we used a one-sided hypergeometric test [26] to
compute the overrepresentation of each ontology term in the cor-
responding DPA. To assess whether a putative ontology term is rel-
evant to a domain, the PubMed abstracts can be divided into four
different categories, using the clinical trial domain as an example:
(1) PubMed abstracts that contain both the putative ontology term
and the domain term ‘‘Clinical Trial” or ‘‘Clinical-Trial” (top left cell
in Fig. 2A, the number of these abstracts = X); (2) PubMed abstracts
that contain only the putative ontology term but not the domain
term (top middle cell in Fig. 2A, the number of these
abstracts = K  X); (3) PubMed abstracts that contain the domain
term but not the putative ontology term (left middle cell in
Fig. 2A, the number of these abstracts =M  X); and (4) PubMed
abstracts that contain neither the putative ontology term nor the
domain term (middle cell in Fig. 2A, the number of these
abstracts = N(K  X)). Therefore, the total number of PubMed ab-
stracts that contains the domain term is M, the total number of
PubMed abstracts that contains the putative ontology term is K,
and the total number of PubMed abstracts is M + N. For a givenputative ontology term, the probability of getting X number of
annotated abstracts among M number of abstracts that contain
the domain term, given that the total number of abstracts contain-
ing the putative ontology term is K , is shown in Fig. 2B [29]. Due to
the discreteness of the hypergeometric distribution, mid-p-values
[30] were used in the test: pmid ¼ PðX > xÞ þ 0:5PðX ¼ xÞ, where
PðX > xÞ is the probability of observing more than x abstracts anno-
tated with both the putative ontology and domain terms, and
PðX ¼ xÞ is the probability of observing exactly x abstracts. We
used the hypergeometric distribution functions (i.e. dhyper and
phyper) implemented in the statistics package of R [31] to perform
the one-sided test (for a discussion about one-sided and two-sided
tests, see [26]) and to calculate the mid-p-value. The null and alter-
native hypotheses for the one-sided test are H0 : r1 6 r2 and
H1 : r1 > r2, respectively; where r1 is the probability of the ontol-
ogy term being relevant to the domain, while r2 is the probability
of the ontology term being relevant to other domains. The resulting
p-value indicates the degree of overrepresentation of the term in
the PubMed abstracts discussing the domain term ‘‘Clinical Trial”
or ‘‘Clinical-Trial”. In order to perform this test in a high-through-
put manner, we also implemented analysis software in C++ to per-
form the test using the functions (gsl_ran_hypergeometric_pdf and
gsl_cdf_hypergeometric_P) in the GNU scientiﬁc library [32].
We tested the overrepresentation of each term under the corre-
sponding chosen domain (i.e. ‘‘Monosaccharide [Metabolic Pro-
cess]”, ‘‘Protein Kinase [Activity]”, and ‘‘Clinical Trial”) against all
the abstracts in PubMed. Recall and Precision were calculated for
different p-value cut offs, where Recall ¼ True PositiveTrue PositiveþFalse Negative and
Precision ¼ True PositiveTrue PositiveþFalse Positive. A Precision–Recall curve generated
from ROCR [33] was used to plot each test and to evaluate the text-
mining method. To evaluate whether child terms were overrepre-
sented for the domain terms Monosaccharide [Metabolic Process]
or Protein Kinase [Activity], we randomly sampled 100 times the
same number of control terms as the child terms to evaluate our
method. We also applied the hypergeometric test to assess
whether the distribution of Clinical Data Interchange Standards
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DPA containing the domain term ‘‘Clinical Trial” or ‘‘Clinical-Trial”.
We then compared our hypergeometric enrichment test-based
approach to a similar approach based on theWeirdness Metric pro-
posed by Ahmad and Rogers [17]. This approach counts the fre-
quency of a term in the DPA and non-DPA and then takes the
ratio of these two frequencies to generate the Weirdness Metric.
We used this approach to test the overrepresentation of each term
under the corresponding chosen domain (i.e. ‘‘Monosaccharide
[Metabolic Process]” and ‘‘Protein Kinase [Activity]”) against all
the abstracts in PubMed and compared the Precision–Recall curves
of this approach with our hypergeometric enrichment test.Fig. 3. Hypergeometric test can be applied to identify children of a particular
Biological Process ontology term in well-developed Gene Ontology. (A) The
occurrence of child terms of Monosaccharide Metabolic Process in PubMed
Abstract. X axis is the frequency of each term in the entire PubMed abstracts in
logarithmic scale. Y axis is the number of terms at a particular frequency. Terms are
binned together based on their frequency. (B) The Precision/Recall curve created for
the overrepresentation of all the children of parent term ‘‘Monosaccharide
Metabolic Process” in the abstracts that contain the parent term. These curves
indicate that the hypergeometric test (solid line) or Weirdness Metric (dashed line
indeed can identify the children (ontology terms) of the parent term (domain), and
the result of this computational method is consistent with the Gene Ontology
created by domain experts.3. Results
We examined 8355343 PubMed abstracts, and the number of
abstracts that contained ‘‘Monosaccharide [Metabolic Process]”
and ‘‘Protein Kinase [Activity]” were 4241 and 86531, respectively.
Out of 56 ‘‘Monosaccharide [Metabolic Process]” children, 39 could
be mapped to the PubMed abstracts, and 63 out of 97 ‘‘Protein
Kinase [Activity]” children could be mapped. In addition, 588
randomly selected GO terms that had no parent-child relationship
to ‘‘Monosaccharide [Metabolic Process]” and ‘‘Protein Kinase
[Activity]” were used as control. The distribution of the occurrence
of these terms in PubMed abstracts is shown in Figs. 3 and 4A for
‘‘Monosaccharide [Metabolic Process]” and ‘‘Protein Kinase [Activ-
ity]”, respectively.
The hypergeometric distribution test showed that a majority of
the children of ‘‘Monosaccharide [Metabolic Process]” were
overrepresented in the abstracts that contained the word ‘‘Mono-
saccharide [Metabolic Process]”. This also held true for the children
of ‘‘Protein Kinase [Activity]”. The results from the GO analysis are
shown in the Precision–Recall curves (Figs. 3 and 4B, solid line). We
achieved a Precision of 0.84 at the Recall level of 0.77 (F-mea-
sure = 0.8) for Monosaccharide [Metabolic Process] and a Precision
of 0.89 at the Recall level of 0.88 (F-measure = 0.88) for Protein
Kinase [Activity]. The corresponding Precision and Recall rates for
the Weirdness Metric approach [17] were 0.83 and 0.77 (F-mea-
sure = 0.8) for Monosaccharide Metabolic Process and 0.84, 0.88
(F-measure = 0.86) for Protein Kinase [Activity], respectively,
indicating our approach performed slightly better.
In order to apply the same test to evaluate the appropriateness
of putative ontology terms for the clinical trial domain, we per-
formed two tests. First, we tested whether selected GO terms could
be separated from the putative ontology terms for the clinical trial
domain. We picked 300 terms from the putative ontology term list
and randomly assigned them into three groups, with each group
having 100 terms. As a control, three groups of control GO terms
with 100 terms each were generated. We used one group of puta-
tive ontology terms and one group of GO terms to test whether
these terms were overrepresented in the DPA that contained the
domain term ‘‘Clinical Trial” or ‘‘Clinical-Trial”. The test was
performed for the other two pairs as well, and the Precision–Recall
curve for the analysis is shown in Fig. 5A. The (Precision, Recall, F-
measure) for these three tests were (0.74, 0.85, 0.79), (0.86, 0.86,
0.86) and (0.85, 0.81, 0.83), respectively, indicating that the enrich-
ment test indeed separated putative ontology terms for the clinical
trial domain from control GO terms. We also selected the p-value
0.0744 that gave the highest F-measure (Fig. 5B) as the threshold
to evaluate all putative ontology terms downloaded from the
CTO wiki. Note that this threshold functioned to separate
putative ontology terms for clinical trial domain from GO terms.
Using 85881 PubMed abstracts that contained the terms ‘‘Clinical
Trial” or ‘‘Clinical-Trial,” we classiﬁed a term as overrepresented
if its p-value from the hypergeometric test was less than 0.0744.)By this standard, twenty two percent of the terms were not over-
represented while the rest, seventy eight percent, were (Fig. 5C).
Table 1 lists some selected representative terms and their enrich-
ment p-values.
In order to further assess this evaluation, we took advantage of
existing terms known to be relevant to the clinical trial domain.
The CDISC glossary has been adopted by the FDA as the data stan-
dard for clinical trials. Therefore, terms from CDISC were used as
positive controls, testing whether they were overrepresented in
the DPA relevant to the clinical trial domain. We identiﬁed 136
terms in CDISC that had exact matches with the putative ontology
terms downloaded from the CTO wiki. Eighty seven percent
(n = 119) of these 136 terms were classiﬁed as overrepresented
in the DPA for clinical trial domain, where only thirteen percent
ig. 5. Separation of terms for developing Clinical Trial ontology and identifying
relevant ontology terms randomly selected from Gene Ontology. (A) The Precision/
ecall curves for three sets of data; each set contains the terms assembled by experts
r developing the Clinical Trial ontology, as well as randomly selected ontology
rms from GO. The overrepresentation of each data set was computed under the
omain terms ‘‘Clinical Trial” or ‘‘Clinical-Trial”. (B) p-value from three tests in (A)
here highest F-measures were obtained. (C) Terms developed by experts are
valuated using the p-value = 0.0744 as a threshold for enrichment test. The list of
Fig. 4. Hypergeometric test can be applied to identify children of a particular
Molecular Function ontology term in well-developed Gene Ontology. (A) The
occurrence of children of ‘‘Protein Kinase Activity” in PubMed Abstract. X axis is the
frequency of each term in the entire PubMed abstracts in logarithmic scale. Y axis is
the number of terms at a particular frequency. Terms are binned together based on
their frequency. (B) The Precision/Recall curve created for the overrepresentation of
all the children of parent term ‘‘Protein Kinase Activity” in the abstracts that contain
the parent term, indicating that the same enrichment test also applies to a second
domain of a well-developed ontology. For all these terms, the common words
‘‘metabolic”, ‘‘catabolic”, ‘‘biosynthetic”, ‘‘process” and ‘‘activity” were removed.
Hypergeometric test – solid line. Weirdness Metric – dashed line.
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category (Fig. 5D, and a set of selected terms are included in Table
1). A one-tailed hypergeometric test indicated that the probability
for such an enrichment level to occur was 0.0003. Therefore, our
approach demonstrated that terms’ overrepresentation in the
DPA indicated relevance to the domain, and the method provided
an objective and effective way to evaluate terms for ontology
development.rms and their p-values are in the supplemental Table 1. About 22% of the terms are
ot overrepresented in the abstracts that have the term ‘‘Clinical Trial” or ‘‘Clinical-
rial”. (D) Out of 316 terms developed by experts, there are 136 terms in the glossary
f CDISC. For these 136 terms, 87% (119) are evaluated as overrepresented in the
ubMed abstracts that contain ‘‘Clinical Trial” or ‘‘Clinical-Trial”. A hypergeometric
st indicates that this distributionhad ap-value of 0.0003, indicating our enrichment
st on 316 terms indeed had a strong bias toward terms involved in clinical trials.4. Discussion
Ontology development is typically a community effort involving
many expert individuals. Their backgrounds and experience will
and should affect ontology development. Despite their expertise,
however, an initial term list developed by many people will
contain many terms that may not ultimately be deemed relevantF
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teto the intended domain for ontology development. The algorithm
we have developed provides an objective assessment of terms that
Table 1
Selected putative ontology terms for clinical trial domain. Terms were assembled by domain experts and evaluated using a hypergeometric enrichment test. A threshold is
determined using the p-value that generates the highest F-measure to separate clinical trial terms from irrelevant terms (Fig. 5C). CDISC terms are also indicated. The full list of
the terms is provided as Supplemental material.
Terms Included in CDISC p-Value one sided (All) p-Value < 0.074 Included in CDISC with signiﬁcant p-value
Adverse event Yes 0.00 Yes Yes
Cohort Yes 0.00 Yes Yes
Efﬁcacy Yes 0.00 Yes Yes
Group sequential Yes 0.00 Yes Yes
Missing data Yes 0.00 Yes Yes
Trial-design No 0.01 Yes No
Treatment-assignment No 0.01 Yes No
Independent review board No 0.02 Yes No
Enrolled population Yes 0.02 Yes Yes
Excluded population No 0.02 Yes No
Assessment schedule No 0.03 Yes No
Permuted block randomization No 0.04 Yes No
Data collection schedule Yes 0.05 Yes Yes
Diagnostic trial No 0.06 Yes No
Nutrient No 0.12 No No
Electronic signature Yes 0.22 No No
Vulnerable subject Yes 0.31 No No
Document role Yes 0.49 No No
Supplier Yes 0.55 No No
Positive control No 0.66 No No
Survey Yes 0.90 No No
Negative control No 1.00 No No
Case history Yes 1.00 No No
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variety of sources. Unlike many other term extraction algorithms,
the hypergeometric enrichment test used all PubMed abstracts
and did not require an a priori corpus of literature for a speciﬁc
domain. The PubMed abstracts for the domain are simply identi-
ﬁed by identifying domain terms in these abstracts. Our method
performed slightly better than a similar approach using the Weird-
ness Metric [17]. In addition, since the Weirdness Metric is
calculated only from the ratio of two frequencies of word occur-
rence, our approach provided statistical means to assess terms
based on their overrepresentation as determined by a hypergeo-
metric enrichment test.
One challenge of our approach is that some terms may not map
to any PubMed abstract. While this circumstance may affect the
method’s (as well as other methods’) ability to evaluate every
single term important for ontology development, a signiﬁcant
percentage of terms indeed can bemapped to the PubMed abstracts
at high or median frequencies, consistent with the observation by
Verspoor et al. [35]. In the relatively rare situation in which a
domain term cannot be mapped to any PubMed abstract, ontology
developers should consider identifying potential synonyms or
semantic equivalents. We also noted that existing ontologies such
as GO containmany artifacts in order to deﬁne their terms precisely.
These artifacts may prevent the terms from being mapped to Pub-
Med abstracts. However, compared to developed ontology terms,
the putative terms that are hand-selected by experts contain fewer
of these artifacts, are closer to the linguistic phrases used in the
literature, and are suitable to be evaluated by our approach.
The diverse topics, synonyms, and semantic variants may also
have signiﬁcant impacts on mapping efﬁciency. After all, research-
ers often use different terms to describe research results. Despite
the fact that researchers in the ﬁeld of Natural Language Processing
and text mining have made progress in this mapping effort [14,35–
37], it remains difﬁcult to identify all PubMed abstracts relevant to
a particular term. Hypergeometric enrichment testing can provide
a certain degree of tolerance to the inefﬁcient mapping of terms to
PubMed abstracts, especially since the ratio between the frequency
of a term in domain speciﬁc and non-domain speciﬁc abstracts (x/
(k  x) from Fig. 2) is likely to be the same as the ratio for the syn-onyms/syntactic variants of the term. Under such conditions, the
probability of observing a term in the DPA would remain at similar
levels to its syntactic variants/synonyms, and the overrepresenta-
tion could still be detected.
Our approach surveys all PubMed abstracts to perform the
hypergeometric test instead of focusing on a pre-determined
corpus of abstracts for some specialized ﬁeld. However, the hyper-
geometric test takes into consideration four different categories of
PubMed abstracts (Fig. 2). The combination of three of these cate-
gories (PubMed abstracts containing: (1) both ontology and the
domain term; (2) ontology terms but not the domain term; (3)
the domain term but not ontology terms) can be viewed as a cor-
pus. Based on the distribution of ontology and domain terms
among these categories, each abstract that has both the domain
term and the child term increases our conﬁdence that the two
are relevant. The mapping of terms also helps us to separate com-
monly used terms that are widely used by the community from
obscure terms that are rarely used. Terms that are present with
high frequency in the abstracts may have a better chance to be
adopted as ontology terms since these are common terms already
widely accepted by the research community. Finally, we are aware
that current mapping does not identify all relevant articles through
PubMed abstracts (i.e. terms are not mentioned in the abstract but
are used in the text). However, for those terms we are able to iden-
tify, our approach showed that the enrichment test can prioritize
relevant terms for ontology development.
We noticed that a number of putative ontology terms were not
overrepresented, and their enrichment p-values were very high.
Judged by domain experts we consulted, these few terms were
very general and their uses were not limited to clinical trials. As
a result, these terms would likely have lower priority for ontology
development in the clinical trial domain. A high p-value may also
indicate the ambiguity of a term. The speciﬁcity or ambiguity of
a term is typically associated with its use across many different
contexts. Therefore, ambiguous terms are used for many different
domains, and their degree of overrepresentation in a particular
domain is less than terms with very speciﬁc meanings for that
domain. For a term that is important to a domain (such as ‘‘With-
drawal Consent” and ‘‘Electronic Signature” for the clinical trial do-
830 L.C. Tsoi et al. / Journal of Biomedical Informatics 42 (2009) 824–830main in Table 1), a high enrichment p-value may also suggest that a
namespace would be needed to avoid ambiguity and to distinguish
the use of such terms within the intended domain from its use in
other domains.
Our approach may help to develop an automatic/semi-auto-
matic approach for ontology development. Ontology development
largely relies on scientiﬁc facts to depict the reality of an intended
domain. Often, a set of review articles and textbook chapters can
capture these facts in great detail for a particular domain. Putative
ontology terms can be extracted from this corpus of selected arti-
cles and evaluated against the domain using our hypergeometric
enrichment test. In addition, the enrichment p-value can serve as
a quantitative measure of the relevance of a putative term to the
domain term. Speciﬁc (child) terms may be overrepresented to a
greater degree than a general (parent) term in the DPA. Therefore,
the enrichment p-value may be used as a measure to place terms
within an ontology hierarchy. Such a scenario may help to improve
the efﬁciency of the current ontology development process and
alleviate burdens on ontology developers/curators.
5. Conclusion
We have developed a computational method that utilizes a
text-mining approach based on hypergeometric enrichment test
to evaluate terms for ontology development. We analyzed the
occurrence of terms in the PubMed database and evaluated their
relevance for ontology development for a particular domain. Such
an application can facilitate the current manual process for ontol-
ogy development.
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